0000899243-19-013992.txt : 20190517
0000899243-19-013992.hdr.sgml : 20190517
20190517161058
ACCESSION NUMBER: 0000899243-19-013992
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190515
FILED AS OF DATE: 20190517
DATE AS OF CHANGE: 20190517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOPER GLENN L MD
CENTRAL INDEX KEY: 0001046351
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 19835756
MAIL ADDRESS:
STREET 1: C/O 99 HAYDEN AVE
STREET 2: 1 LEDGEMONT CENTER
CITY: LEXINGTON
STATE: MA
ZIP: 02173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-15
0
0000730272
REPLIGEN CORP
RGEN
0001046351
COOPER GLENN L MD
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
1
0
0
0
Common Stock
2019-05-15
4
A
0
923
0.00
A
40709
D
Stock Option (Right to Buy)
67.71
2019-05-15
4
A
0
2109
0.00
A
2020-05-15
2029-05-15
Common Stock
2109
2109
D
Mr. Cooper was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Award vests in full one year from grant date on May 15, 2020.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2019-05-17